VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Little is known about the factors that enable the mobilisation of human mesenchymal stem cells (MSC) from the bone marrow into the blood stream and their recruitment to and retention in the tumour. We found specific migration of MSC towards growth factors present in pancreatic tumours, such as PDGF, EGF, VEGF and specific inhibitors Glivec, Erbitux and Avastin interfered with migration. Within a few hours, MSC migrated into spheroids consisting of pancreatic cancer cells, fibroblasts and endothelial cells as measured by time-lapse microscopy. Supernatant from subconfluent MSC increased sprouting of HUVEC due to VEGF production by MSC itself as demonstrated by RT-PCR and ELISA. Only few MSCs were differentiated into endothelial cells in vitro, whereas in vivo differentiation was not observed. Lentiviral GFP-marked MSCs, injected in nude mice xenografted with orthotopic pancreatic tumours, preferentially migrated into the tumours as observed by FACS analysis of green fluorescent cells. By immunofluorescence and intravital microscopic studies, we found the interaction of MSC with the endothelium of blood vessels. Mesenchymal stem cells supported tumour angiogenesis in vivo, that is CD31(+) vessel density was increased after the transfer of MSC compared with siVEGF-MSC. Our data demonstrate the migration of MSC toward tumour vessels and suggest a supportive role in angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both BM- and adipose-derived MSC display tumor tropism due to various tumor-released chemotactic factors including CCL25 [43], C-X-C motif chemokine-1 (CXCL1) [54], epidermal growth factor (EGF) [83, 84], hepatoma-derived growth factor (HDGF) [85], IL-8 [54], platelet-derived growth factor (PDGF) [84], stromal cell-derived factor-1 (SDF1, a.k.a. CXCL12) [86, 87], TGFβ [88], and VEGF [84].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BM-MSC and ASC can also secrete a combination of anti-apoptotic and angiogenic factors [121], including HGF, SDF-1/CXCL12, CD106 (sVCAM) and VEGF which can promote tumor growth, local angiogenesis and metastasis [42, 84, 122–127].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [84]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other factors with potential pro-angiogenic effect are angiogenin and CCL2 in lymphoma and hepatocyte growth factor, cyclooxygenase, IGF-1 and transforming growth factor-a1 in pancreatic carcinoma [45].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedMultilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354 · cited 2×
“As VLA-4 is known to be expressed on MSC and VCAM-1 on inflamed vascular endothelium (Ley et al, 2007), one may hypothesise an in vivo relevance of the interaction of these two molecules during MSC recruitment as supported by recent studies (Ruster et al, 2006; Segers et al, 2006).”
BackgroundResultMolecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro
Oswald, J., Boxberger, S., Jørgensen, B., Feldmann, S., Ehninger, G., Bornhäuser, M., & Werner, C. (2004) · STEM CELLS · doi:10.1634/stemcells.22-3-377 · Cited by 1,317
Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
(2002) · PubMed · Cited by 903
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 842
Silva, G. V., Litovsky, S., Assad, J. A. R., Sousa, A. L. S., Martin, B. J., Vela, D., Coulter, S. C., Lin, J., Ober, J., Vaughn, W. K., et al. (2005) · Circulation · doi:10.1161/01.cir.0000151812.86142.45 · Cited by 801
Creation of long-lasting blood vessels
Koike, N., Fukumura, D., Gralla, O., Au, P., Schechner, J. S., & Jain, R. K. (2004) · Nature · doi:10.1038/428138a · Cited by 701
Chen, J., Zhang, Z. G., Li, Y., Wang, L., Xu, Y. X., Gautam, S. C., Lu, M., Zhu, Z., & Chopp, M. (2003) · Circulation Research · doi:10.1161/01.res.0000063425.51108.8d · Cited by 652
Giordano, A., Galderisi, U., & Marino, I. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20959 · Cited by 609
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
Rüster, B., Göttig, S., Ludwig, R. J., Bistrian, R., Müller, S., Seifried, E., Gille, J., & Henschler, R. (2006) · Blood · doi:10.1182/blood-2006-05-025098 · Cited by 562
Au, P., Tam, J., Fukumura, D., & Jain, R. K. (2008) · Blood · doi:10.1182/blood-2007-10-118273 · Cited by 562
Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M., Yamagishi, M., Mori, H., Kangawa, K., & Kitamura, S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01071.2003 · Cited by 519
Mahmood, A., Lu, D., Lu, M., & Chopp, M. (2003) · Neurosurgery · doi:10.1227/01.neu.0000079333.61863.aa · Cited by 478
Barry, F. P., Boynton, R. E., Haynesworth, S., Murphy, J. M., & Zaia, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1620 · Cited by 402
KORFF, T., KIMMINA, S., MARTINY‐BARON, G., & AUGUSTIN, H. G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0139com · Cited by 369
Erkan, M., Kleeff, J., Gorbachevski, A., Reiser, C., Mitkus, T., Esposito, I., Giese, T., Büchler, M. W., Giese, N. A., & Friess, H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.031 · Cited by 305
Self-citationPancreatic cancer–associated stroma production
Korc, M. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.05.004 · Cited by 268
Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells
Schmidt, A., Ladage, D., Schinköthe, T., Klausmann, U., Ulrichs, C., Klinz, F., Brixius, K., Arnhold, S., Desai, B., Mehlhorn, U., et al. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0191 · Cited by 237
Long, D. S., Smith, M. L., Pries, A. R., Ley, K., & Damiano, E. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402937101 · Cited by 210
Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms
Segers, V. F. M., Van Riet, I., Andries, L. J., Lemmens, K., Demolder, M. J., De Becker, A. J. M. L., Kockx, M. M., & De Keulenaer, G. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00523.2005 · Cited by 204
Isolation and identification of mesenchymal stem cells from human fetal pancreas
Hu, Y., Liao, L., Wang, Q., Ma, L., Ma, G., Jiang, X., & Zhao, R. C. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00022-2 · Cited by 192
Bos, R., Van Diest, P. J., De Jong, J. S., Van Der Groep, P., Van Der Valk, P., & Van Der Wall, E. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02045.x · Cited by 180
Mesenchymal stem cells transmigrate over the endothelial barrier
Schmidt, A., Ladage, D., Steingen, C., Brixius, K., Schinköthe, T., Klinz, F., Schwinger, R. H. G., Mehlhorn, U., & Bloch, W. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.05.015 · Cited by 131
Role of hypoxia-inducible factor-1α as a cancer therapy target
Patiar, S., & Harris, A. L. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01290 · Cited by 125
Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase–deficient mice
Sperandio, M., Thatte, A., Foy, D., Ellies, L. G., Marth, J. D., & Ley, K. F. (2001) · Blood · doi:10.1182/blood.v97.12.3812 · Cited by 116
Song, Y. S., Lee, H. J., Park, I. H., Kim, W. K., Ku, J. H., & Kim, S. U. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901539 · Cited by 93
Sanz, L., Santos-Valle, P., Alonso-Camino, V., Salas, C., Serrano, A., Vicario, J. L., Cuesta, Á. M., Compte, M., Sánchez‐Martín, D., & Álvarez‐Vallina, L. (2008) · Microvascular Research · doi:10.1016/j.mvr.2007.11.007 · Cited by 86
Korff, T., Krauss, T., & Augustin, H. G. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.043 · Cited by 73
Sun, B., Zhang, S., Ni, C., Zhang, D., Liu, Y., Zhang, W., Zhao, X., Zhao, C., & Shi, M. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.292 · Cited by 72
Fukuda, K., & Fujita, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00624.x · Cited by 70
α2,3‐Sialyltransferase‐IV is essential for L‐selectin ligand function in inflammation
Sperandio, M., Frommhold, D., Babushkina, I., Ellies, L. G., Olson, T. S., Smith, M. L., Fritzsching, B., Pauly, E., Smith, D. F., Nobiling, R., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200636157 · Cited by 68
Self-citationKallifatidis, G., Beckermann, B. M., Groth, A., Schubert, M., Apel, A., Khamidjanov, A., Ryschich, E., Wenger, T., Wagner, W., Diehlmann, A., et al. (2008) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701097 · Cited by 63
Self-citation16 Mesenchymal Stem Cells of Human Adult Bone Marrow
Pittenger, M. F., & Marshak, D. R. (2001) · Cold Spring Harbor Monograph Archive · doi:10.1101/087969673.40.349 · Cited by 63
Target Therapy Using a Small Molecule Inhibitor against Angiogenic Receptors in Pancreatic Cancer
Büchler, P., Reber, H. A., Roth, M. M., Shiroishi, M. S., Frieß, H., & Hines, O. J. (2007) · Neoplasia · doi:10.1593/neo.06616 · Cited by 37
Self-citationSipos, B., Weber, D., Ungefroren, H., Kalthoff, H., Zühlsdorff, A., Luther, C., Török, V., & Klöppel, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10753 · Cited by 31
Reinmuth, N., Rensinghoff, S., Raedel, M., Fehrmann, N., Schwöppe, C., Keßler, T., Bisping, G., Hilberg, F., Roth, G. J., Berdel, W. E., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.621 · Cited by 23
Cited by
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications
Rani, S., Ryan, A. E., Griffin, M. D., & Ritter, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.44 · Cited by 1,227
Immunobiology of mesenchymal stem cells
Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y., & Wang, Y. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.158 · Cited by 771
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Lee, J.-K., Park, S.-R., Jung, B.-K., Jeon, Y.-K., Lee, Y.-S., Kim, M.-K., Kim, Y.-G., Jang, J.-Y., & Kim, C.-W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084256 · Cited by 642
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Metadata
- Authors
- Beckermann, B. M., Kallifatidis, G., Groth, A., Frommhold, D., Apel, A., Mattern, J., Salnikov, A. V., Moldenhauer, G., Wagner, W., Diehlmann, A., Saffrich, R., Schubert, M., Ho, A. D., Giese, N., Büchler, M. W., Friess, H., Büchler, P., & Herr, I.
- Affiliations
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Corresponding author
- Herr, I
- ORCID
- Venue
- British Journal of Cancer
- Published
- 2008-07-29
- Volume
- 99
- Issue
- 4
- Pages
- 622-631
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2527820
- OpenAlex
- W2001213911
- Cited by
- 406
- References
- 41
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 19 · 2023: 22 · 2022: 26 · 2021: 28 · 2020: 24 · 2019: 35 · 2018: 25 · 2017: 18 · 2016: 25 · 2015: 24 · 2014: 23 · 2013: 27 · 2012: 21
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Funders
- Bundesministerium für Bildung und Forschung
- Deutsche Krebshilfe
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- mesenchymal stem cells, vascular endothelial growth factor, tumor angiogenesis, pancreatic cancer, tumor cell migration, tumor microenvironment, platelet-derived growth factor, epidermal growth factor, VEGF inhibitors, endothelial sprouting, tumor vasculature, tumor cell differentiation
- MeSH terms
- Bevacizumab, Cetuximab, Imatinib Mesylate, Actins, Animals, Antibodies, Monoclonal, Antineoplastic Agents, Benzamides, Cell Differentiation, Cell Movement, Cells, Cultured, Endothelium, Vascular, Epidermal Growth Factor, Fibroblasts, Humans, Male, Mice, Nude, Muscle, Smooth, Neovascularization, Pathologic, Pancreatic Neoplasms, Piperazines, Platelet-Derived Growth Factor, Pyrimidines, Transplantation, Heterologous, Umbilical Veins, Lentivirus, Spheroids, Cellular, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Mesenchymal Stem Cell Transplantation, Cell Proliferation, Mice, Mesenchymal Stem Cells, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.